Together, RUNX2 and HIF-1α collaboratively enhance the metastatic and invasive potential of osteosarcoma, where RUNX2 upregulates MMPs and other enzymes to degrade the extracellular matrix and HIF-1α supports this process through EMT (Table S3). The gene discussed is HIF1A; the disease is osteosarcoma.